Home › NCT06373328
Post Pandemic Pneumococcal Carriage Among Children and Adults
Post-Pandemic Genomic Epidemiology of Pneumococcal Carriage Among Children and Adults in the General US Population
Who can join
7 Months · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Children, ages 7 to 59 months (less than 5 years) * Adults, ages 50 and older * Ability to provide informed consent (from parents for children participants) * ability to read and speak in English * Agree to comply with study procedures (complete online data questionnaire and provide a nasopharyngeal collection). Exclusion Criteria: * Have been on an antibiotic in the last 2 weeks * Have a respiratory infection that would make an nasopharyngeal collection improbable * Have underlying developmental or chronic conditions impacting immune or respiratory function (e.g., immunocompromised, cystic fibrosis, cerebral palsy, paralysis) * Adults unable to consent, individuals who are not yet adults, and prisoners will be excluded from this study.
About the study
The PI propose to conduct a genomic epidemiology study of pneumococcal carriage among children and adults in a large metropolitan city. These data will allow PI to assess the post-pandemic population structure, investigate the phylogenetic relationship between isolates from children and adults, and compare pneumococcal populations across diverse geographic areas.
Sponsor: University of Central Florida · Participants: 900 · Started: Jun 12, 2024
Contact the study team
- Amoy Fraser, PhD, CCRP, PMP · Phone: 4072668742
- Erica Martin, B.S. · Phone: 4072668742
Official record on ClinicalTrials.gov — NCT06373328
Locations in the U.S.
| Florida | University of Central Florida, Orlando |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.